Northern Trust
SKYE icon

Northern Trust’s Skye Bioscience SKYE Stock Holding History

Northern Trust’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.1K Buy
7,041
+4,523
+180% +$28.5K ﹤0.01% 4301
2026
Q1 		$12.4K Hold
2,518
– – ﹤0.01% 4369
2025
Q4 		$15.1K Sell
2,518
-1,108
-31% -$12.9K ﹤0.01% 4412
2025
Q3 		$114K Hold
3,626
– – ﹤0.01% 4106
2025
Q2 		$121K Sell
3,626
-13,570
-79% -$225K ﹤0.01% 4069
2025
Q1 		$219K Buy
17,196
+232
+1% +$5.07K ﹤0.01% 3914
2024
Q4 		$384K Sell
16,964
-646
-4% -$21.6K ﹤0.01% 3751
2024
Q3 		$551K Buy
17,610
+12,301
+232% +$552K ﹤0.01% 3555
2024
Q2 		$340K Buy
+5,309
New +$504K ﹤0.01% 3650

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust's SKYE Position: Q2 2026 in Review

Northern Trust increased its Skye Bioscience (SKYE) stake by 180% in Q2 2026, buying an estimated $28.5K and bringing the position to 7,041 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4301.

Northern Trust first reported a position in SKYE in Q2 2024 and has held it in 9 quarters since. The position peaked at $551K in Q3 2024. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Northern Trust held 7,041 shares of Skye Bioscience worth $39.1K as of Q2 2026.
  • Northern Trust bought 4,523 Skye Bioscience shares in Q2 2026, an estimated $28.5K.
  • Skye Bioscience made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4301 holding.
  • Northern Trust first reported a position in Skye Bioscience in Q2 2024 and has held it in 9 quarters since.
  • Northern Trust's Skye Bioscience position peaked at $551K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.